Press release
Pharmaceutical Service Provider Vetter Pharma to Build New Manufacturing Site in Germany
Aerial view of the 95-acre industrial site in acquired by Vetter
- Building permit application for German site submitted
- Construction start is scheduled for the 2nd quarter 2026, with operational readiness in 2031
- Expansions in the US and Europe are included in a €1.5 billion investment plan
Ravensburg, January 29, 2026: Vetter, one of the world's leading pharmaceutical service providers for the production of injectable drugs, has confirmed its plans to build a state-of-the-art production facility in the Saarland region of southwest Germany. This strategic investment marks a significant milestone in the company's long-term global growth strategy. Construction is scheduled to begin in the second quarter of 2026. Initially, approximately €480 million have been allocated for the first construction phase of the new commercial production plant. Operations are expected to commence in 2031.
The Contract Development and Manufacturing Organization (CDMO) acquired the approximately 95-acre industrial property in the city of Saarlouis at the end of 2024. This location was chosen following careful strategic investment considerations and supported by significant regional advantages. Vetter sees the potential to create up to 2,000 jobs in the long term. The European Commission has approved up to €47 million of state aid for this extensive project.
"With the construction of our new production facility in Germany, we continue on our path to sustainable growth. Long-term success derives from striking the right balance between stability and expansion," emphasizes Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family. "With our investments in the state of Saarland, only a five hour drive away from our headquarters in Ravensburg, we are strengthening our commitment to Germany's economic landscape while reaffirming our engagement as a strategic partner to the global pharmaceutical market."
In parallel, the company recently began construction on a new clinical production site in Des Plaines, Illinois, USA. This new aseptic manufacturing facility emphasizes Vetter's commitment to providing high-quality services and drug products during early clinical development.
For over 75 years, Vetter has been committed to quality, innovation, and responsibility in the production of sterile pharmaceuticals, improving the lives of patients worldwide. To meet growing customer demand and increasing market requirements, the company is investing in its existing sites in Germany, Austria, and the United States. With its newly planned commercial site, Vetter will significantly expand its production capacity.
Vetter Pharma International GmbH
Markus Kirchner
Corporate Spokesperson / Media Relations
Eywiesenstrasse 5
88212 Ravensburg
Germany
markus.kirchner@vetter-pharma.com
Vetter is a leading Contract Development and Manufacturing Organization (CDMO) with headquarters in Ravensburg, Germany, and production facilities in Germany, Austria, and the US. As a global player, the independent pharmaceutical service provider is also present in the Asia-Pacific markets of Japan, China, South Korea and Singapore with sales locations. Around the world, renowned pharma and biotech companies benefit from decades of experience, high quality, modern technologies, reliability, and commitment of its more than 7,700 employees. In close collaboration with its customers, the Vetter team helps enable the supply to patients all over the world with medicines, many of which are vital. The CDMO provides support from drug product development through clinical and commercial filling to a wide range of assembly and packaging services for vials, syringes, and cartridges. With innovative approaches, Vetter develops prefilled drug-delivery systems together with its customers to continuously improve patient safety, comfort, and compliance. Vetter takes responsibility for sustainable practices and operates as a socially and ethically responsible corporate citizen. The CDMO is a member of the UN Global Compact and Science Based Target initiative (SBTi) and received platinum status in the renowned EcoVadis ranking. Multiple awards such as the CDMO Leadership Awards, Frost & Sullivan Customer Value Leadership Award and the recognition of Best Managed Company emphasize Vetter's commitment to sustainable business. Founded in Ravensburg in 1950, the company remains family-owned to this day. For more information, visit www.vetter-pharma.com and follow Vetter on LinkedIn.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical Service Provider Vetter Pharma to Build New Manufacturing Site in Germany here
News-ID: 4369702 • Views: …
More Releases for German
Elan German Transforms Language Learning Journey for Professionals and Students …
Leading Institute Bridges Language Barriers with Comprehensive A1-B2 Programs, Corporate Training, and Complete Relocation Support
The German language opens doors to Europe's largest economy, world-class universities, and countless career opportunities. Yet many learners struggle with traditional methods that focus on textbook German rather than real-world communication skills. Elan German is changing that narrative.
This specialised language training institute has built its reputation on a simple premise: German fluency isn't just about grammar…
Find the best conditions for your German mortgage with Your German Mortgage
During times of the Coronavirus, we are here to help you with finding the right financing for your property.
Special times call for special measures, that's why it's now more important to find a trustworthy and experienced mortgage broker than ever.
We got you covered from finding your property of dreams all the way to financing it.
To ensure that, we have experts in almost every German major city,…
German Maritime Security 2018, German Government Statement!
Despite all international and national efforts, piracy remains a serious peril for the international shipping industry.
Especially in Asia (i.e. Chittagong/Bangladesh or on the Strait of Malacca), but also in South America (e.g. Bay of Santos/Brazil or in the port of Callao/Peru) robbery or piracy there has recurred in the recent past. At the West African coast the number of incidents had raised even by 50% with 66 incidents this…
German Local Trade Tax
All the companies in Germany are liable to pay not only corporate income tax, whose rate is nowadays about 15% of the annual profit of the company, but also trade tax (Gewerbesteuer), which is a tax of German characteristics.
Why would we say that trade tax is of German characteristics? Because it is different from the corporate income tax, which is charged by the German Federal Government and it is difficult…
Integral Launches German Bureau
Integral Launches German Bureau
Appoints Suchit Manchanda as the Head of Operations
January 4, 2010: Germany: Integral Fusion, a leading software services firm, has launched operations in Germany and announced the appointment of Suchit Manchanda as their Managing Director. The German bureau will be responsible for strategic business development in European Union organizations and client servicing. Suchit a world class MBA from Hochschule Nürnberg, Germany and a Masters in IT from Jamia…
ISPA – German Masters 2008
Magdeburg – Over the long weekend of the 4. Mai more than 1.000 Skat players filled the Mittelland hall in Barleben. The tournaments of the 30. German Mastery and the 27. open International German Single Mastership were held by the International Skat Players Association, ISPA Germany. Patrons of the Games were the 1st Barleber Skat sports club e.V. and the Skat club \"Burger Ihleskater\", whose good organization together with the…
